angiotensin II receptor blockers, telmisartan
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2008 Sep 18;359(12):1225-37 Randomized Controlled Trial, Multicenter Study
IN stroke, ischemic, with or without hypertension The Use of
angiotensin II receptor blockers, telmisartan
As Treatment, Chronic
Is equal Than
placebo
To reduce at 2.5 years recurrent stroke (8.7% telmisartan VS 9.2% placebo) or cardiovascular events (13.5% telmisartan VS 14..4% placebo)